Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Agreement with Boston Globe Media Group

9 Oct 2015 07:00

RNS Number : 7432B
Phorm Corporation Limited
09 October 2015
Β 

9 OctoberΒ 2015

Β 

PhormΒ CorporationΒ Limited

("Phorm"Β orΒ theΒ "Company")

Agreement with Boston Globe Media Group

Phorm (AIM: PHRM), an advertising-technology company, is pleased to announce, further to its interim results released on 30 September 2015, that Boston Globe Media Group ("Boston Globe"), a leading U.S. digital media group, is implementing the Company's targeted advertising technology on its digital properties.

Β 

Phorm's cutting-edge Machine-Learning Artificial Intelligence ("AI") technology makes it easier and more efficient for publishers (and other sellers of advertisements) to identify and target specific audiences and extend audience reach to ultimately achieve more successful advertising campaigns. The Company's proprietary technology also provides unrivaled insight into digital advertising supply and demand dynamics such that publishers can regain more control of their advertising inventory.

Β 

Recognising the potential value and benefits of Phorm's software platform, Boston Globe will implement Phorm' technology across its digital properties to seek and achieve increased advertising sales and performance as well as optimised inventory control.

Β 

Boston Globe, through its developing relationship with Phorm, will continue to seek to extend its circa 4 - 5 million unique visitors per month, increase its advertising revenues through new sources, and optimise the revenue potential of all third party partnerships that it is working with, including Phorm.

Β 

Commenting on Boston Globe's decision to implement Phorm's platform, Pete Doucette, VP of Consumer Sales & Marketing, said:

Β 

"We are always looking to increase our revenue and margin, and engage with new users across our various websites and media channels. Phorm's technology will enable us to identify users in a deeper and more meaningful manner during their consumer journey with us and other sites, with an overarching objective of increasing our potential share of advertising spend."

Β 

Phorm's CEO, Timothy Smith, added:

Β 

"We're most energised and excited to be working with such a nationally esteemed brand as the Boston Globe, which is innovating through the use of technology. We are looking forward to demonstrating the power of our technology software platform and contributing to Pete and his team's enhanced understanding of their audience, delivering users more efficiently and recruiting new users of Boston Globe's content."

Β 

Β 

-Ends-

ForΒ furtherΒ informationΒ pleaseΒ contact:Β 

Phorm Corporation Limited
Timothy Smith (Chief Executive Officer) +44 (0)20 33976001

Β 

MirabaudΒ SecuritiesΒ LLPΒ (Broker) +44 (0)20Β 7321Β 2508

JasonΒ WoollardΒ 

PeterΒ Krens

Β 

StrandΒ HansonΒ LimitedΒ (NominatedΒ Adviser) +44 (0)20Β 7409Β 3494

JamesΒ HarrisΒ MatthewΒ ChandlerΒ JamesΒ Dance

Β 

Β 

AboutΒ Phorm

PhormΒ isΒ aΒ global advertising-technologyΒ companyΒ thatΒ makesΒ contentΒ andΒ advertisingΒ moreΒ relevantΒ toΒ theΒ consumer.Β Phorm'sΒ innovativeΒ platformΒ preservesΒ userΒ privacyΒ andΒ deliversΒ aΒ moreΒ interestingΒ onlineΒ experience.

Β 

Phorm'sΒ industryΒ leadingΒ technologyΒ enablesΒ itsΒ InternetΒ ServiceΒ ProviderΒ ("ISP") and other partnersΒ toΒ offerΒ aΒ newΒ typeΒ ofΒ onlineΒ advertisingΒ platformΒ andΒ aΒ freeΒ consumerΒ internetΒ contentΒ feature,Β ensuringΒ moreΒ relevantΒ advertisementsΒ andΒ personalised content forΒ opted-inΒ users.

Β 

Phorm'sΒ advertisingΒ platformΒ revolutionisesΒ currentΒ standardsΒ ofΒ onlineΒ privacy,Β fullyΒ protectingΒ theΒ identityΒ ofΒ consumers.Β Phorm'sΒ solutionΒ isΒ completelyΒ opt-in.Β OnlyΒ thoseΒ usersΒ consentingΒ toΒ theΒ serviceΒ areΒ profiledΒ andΒ onlyΒ ever onΒ anΒ anonymousΒ basis.

Β 

Phorm's partnersΒ includeΒ leading ISPs,Β Publishers, Advertising NetworksΒ and Advertisers.

Β 

Phorm,Β underΒ aΒ predecessorΒ holding company,Β was admitted to theΒ AIMΒ marketΒ of the London StockΒ ExchangeΒ inΒ 2004.

Β 

ForΒ moreΒ information, pleaseΒ visit:Β www.phorm.com

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
NRADDBDGBBGBGUI
Date   Source Headline
14th Apr 201610:00 amRNSUpdate and Resignation of Nominated Adviser
16th Mar 201612:37 pmRNSIssue of US$500,000 of Convertible Loan Notes
16th Mar 20167:00 amRNSIssue of US$500,000 of Convertible Loan Notes
25th Feb 20168:02 amRNSFunding Update and Statement re Suspension
25th Feb 20167:55 amRNSSuspension - Phorm Corporation Limited
4th Feb 20166:05 pmRNSFunding Update
1st Feb 20163:49 pmRNSSubscription Update, New Subscription & Loan
21st Jan 20167:00 amRNSPhorm Awarded TRUSTe Certified Privacy Seal
18th Jan 20167:00 amRNSSubscription & Operational Update
5th Jan 20162:00 pmRNSTR-1: Notification of major interest in shares
23rd Dec 20151:00 pmRNSRevised Non-Executive Director Compensation
22nd Dec 20157:00 amRNSDirectorate Change
7th Dec 20157:00 amRNSRepricing of Options
3rd Dec 201511:00 amRNSPhorm Enables Hover Rate with Insomnis Media
1st Dec 20157:00 amRNSNew Share Option Plan and Grant of Options
18th Nov 20157:00 amRNSTR-1: Notifications of Major Interests in Shares
28th Oct 20157:00 amRNSPartnering Agreement with INSOMNIS Media Limited
20th Oct 20157:00 amRNSAgreement with Causemo, Inc.
13th Oct 20157:00 amRNSPhorm Hires Chief Revenue Officer
9th Oct 20157:00 amRNSAgreement with Boston Globe Media Group
30th Sep 20151:33 pmRNSInterim Results
28th Aug 20152:38 pmRNSResult of AGM
10th Aug 20157:00 amRNSNotice of Annual General Meeting
7th Aug 20157:48 amRNSEquity fundraising of approximately £3.2 million
29th Jul 20157:02 amRNSUpdate re Board Changes
28th Jul 20157:00 amRNSLoan Agreement & Convertible Loan Note Extension
15th Jul 201511:21 amRNSBoard and Management Changes
3rd Jul 20157:00 amRNSOperational Update
2nd Jul 20157:16 amRNSDirectorate Change
30th Jun 20157:00 amRNSAnnual Financial Report
8th May 20154:00 pmRNSTR-1: Notification of major interest in shares
22nd Apr 20157:00 amRNSEquity Fundraising of £6.0 million Gross
21st Apr 20154:22 pmRNSOperational Update
16th Mar 20153:45 pmRNSDirectorate Change
25th Feb 20157:02 amRNSBoard Changes
19th Jan 20157:00 amRNSEquity fundraising of approximately £6.25 million
16th Jan 20157:21 amRNSOperational Update
8th Dec 20147:00 amRNSEquity Fundraising
28th Oct 20147:00 amRNSTR-1: Notification of major interest in shares
8th Oct 20147:00 amRNSEquity fundraising of £4.47 million
6th Oct 20147:00 amRNSOperational Update
22nd Aug 20147:05 amRNSSubscription To Raise £2.4 million
22nd Aug 20147:00 amRNSInterim Results
24th Jul 20142:31 pmRNSResult of Annual General Meeting
27th Jun 20147:30 amRNSGlobal Operations Update
27th Jun 20147:05 amRNSNotice of Annual General Meeting and Board Changes
27th Jun 20147:00 amRNSFinal Results for the Year Ended 31 December 2013
23rd Apr 20144:25 pmRNSTR-1: Notification of major interest in shares
14th Apr 201412:40 pmRNSResult of EGM
27th Mar 20147:00 amRNSProposed £10m Placing & Notice of EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.